Skip to main content
. Author manuscript; available in PMC: 2008 Dec 26.
Published in final edited form as: Cancer. 2001 Sep 15;92(6):1451–1459. doi: 10.1002/1097-0142(20010915)92:6<1451::aid-cncr1469>3.0.co;2-r

TABLE 1.

Patient Characteristics (N = 256)

Characteristic No. %
Mean age ± SE in yrs (range) 65.0 ± 0.5 (45−80)
Marital status
    Married or in marital relationship 221 86
    Separated, divorced 17 7
    Widowed 12 5
    Never married 6 2
Ethnicity
    Caucasian 229 89
    African-American 27 11
Education (highest level achieved)
    Graduated from high school 68 27
    Graduated from college 62 24
    Postgraduate training 54 21
    Some college 43 17
    Less than high school 29 11
Employment status
    Not working 134 52
    Working 122 48
Religion
    Catholic 116 45
    Protestant 104 41
    Other 18 7
    Judaism 12 5
    Agnostic/atheist 6 2
Type of treatment
    RP 156 61
    BT 51 20
    EBRa 49 19
Adjuvant hormone therapy
    No 216 84
    Yes 40 16
Mean days ± SE since diagnosis (range) 173.5 ± 10.4 (33−1311)
Mean days ± SE since surgery (RP only) (range) 48.0 ± 1.6 (15−98)
Mean days ± SE since seed implants (BT only) (range) 43.2 ± 2.7 (7−87)
Mean days ± SE since start of radiation (EBR only) (range) Mean = 43.5 days, SE = 3.1
TNM stage Range 7−99 days
    T2N0M0 176 69
    T1N0M0 48 19
    T3N0M0 31 12
    Missing 1 < 1
Gleason sum at diagnosis (mean ± SE) 6.1 ± 0.1
Other malignant disease
    No 228 89
    Yes (melanoma only) 28 11
Prostate problem before treatment
    None 185 72
    Benign prostatic hyperplasia 40 16
    Prostatitis 15 6
    Urination difficulties 15 6
    Elevated PSA 1 < 1

SE: standard error; RP: radical prostatectomy; BT: brachytherapy; EBR: external beam radiotherapy; PSA: prostate specific antigen.

a

Thirty patients (61%) received concurrent radiation treatment at the time of data collection.